Evidence map›Paper›PMID 37921463›Full record

ArticlemSystems2023

Ruizhi Tao, Gangfan Zong, Yehua Pan, Hongxing Li, Peng Cheng, Rui Deng, Wenxing Chen, Aiyun Wang, Shishan Xia, Weibing Tang and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Efficacy ofMicroorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ruizhi Tao *Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Gangfan Zong *Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Yehua PanJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Hongxing LiDepartment of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, China.
Peng ChengJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Rui DengJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Wenxing ChenJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Aiyun WangJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Shishan XiaNingbo Women and Children's Hospital, Ningbo, China.
Weibing TangDepartment of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, China.ORCID 0000-0002-3582-3408
Yin LuJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.ORCID 0000-0003-2063-8485
Zhonghong WeiJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.ORCID 0000-0002-1733-6331
Nanjing University of Chinese Medicine · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

National Natural Science Foundation of China 82004124Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) BK20200154The Open Project of State Key Laboratory of Natural Medicines SKLNMKF202301
6 · The paper itself

Abstract

importanceThis study sheds light on that treatment with

Indexed as

Clostridium butyricumClostridium tyrobutyricumEnterocolitis, NecrotizingFetal DiseasesInfant, Newborn, DiseasesProbioticsFemaleHumansInfant, NewbornIntestinesClostridium butyricumClostridium tyrobutyricumintestinal barriernecrotizing enterocolitis

Identifiers

PMID37921463
PMCPMC10734425
OpenAlexW4388290554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.